MCKESSON CORP
8-K/A, 1998-11-06
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: MEDIRISK INC, 4, 1998-11-06
Next: MCKESSON CORP, 424B3, 1998-11-06



<PAGE>
 
 
                     SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549

                                 FORM 8-K/A
                              (AMENDMENT NO. 2)
                               Current Report

                     Pursuant to Section 13 or 15(d) of
                     the Securities Exchange Act of 1934

                               October 19, 1998
- --------------------------------------------------------------------------------
                               (Date of Report)

                               October 17, 1998
- --------------------------------------------------------------------------------
                       (Date of earliest event reported)

                            McKESSON CORPORATION
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in charter)

        Delaware                      1-13252                   94-3207296
- --------------------------------------------------------------------------------
(State or other jurisdiction        (Commission               (IRS Employer
    of incorporation)                File Number)           Identification No.)

              McKesson Plaza 
             One Post Street
        San Francisco, California                                  94104
- --------------------------------------------------------------------------------
(Address of principal executive offices)                        (Zip Code)

- --------------------------------------------------------------------------------
      Registrant's telephone number, including area code (415) 983-8300



<PAGE>
 
 
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
- --------------------------------------------------------------------------

        The undersigned Registrant hereby amends Item 7(b) Pro Forma Combined
Condensed Consolidated Financial Data of McKesson and HBOC in its Current Report
on Form 8-K/A.

        Item 7(b) is hereby amended by deleting it in its entirety and replacing
it with Item 7(b) attached hereto and filed herewith.

        The purpose of this amendment is to reclassify certain noncurrent asset 
balances in the Pro Forma Combined Condensed Balance Sheet at September 30, 
1998. Total asset balances did not change.

                                       2

<PAGE>
 
 
                                  SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this amendment to be signed on its behalf by the 
undersigned hereunto duly authorized.

                                                McKESSON CORPORATION
                                                (Registrant)

Dated: November 6, 1998                         By /s/ Richard H. Hawkins
                                                --------------------------------
                                                Richard H. Hawkins
                                                Vice President and 
                                                Chief Financial Officer

                                                By /s/ Heidi E. Yodowitz
                                                --------------------------------
                                                Heidi E. Yodowitz
                                                Controller

                                       3

<PAGE>
 
 
                    UNAUDITED PRO FORMA COMBINED CONDENSED
                        CONSOLIDATED FINANCIAL DATA OF
                               McKESSON AND HBOC

    On October 18, 1998, McKesson Corporation ("McKesson") announced an
agreement to acquire HBO & Company ("HBOC"). Terms of the merger call for each
HBOC stockholder to receive .37 of a share of McKesson common stock for each
share of HBOC common stock in a tax-free exchange. The merger is subject to
regulatory approval, McKesson and HBOC stockholder approval and other customary
conditions. HBOC and McKesson intend that the merger will be accounted for as a
pooling of interests and expect that it will close in the first quarter of 1999.

    HBOC and Access Health, Inc. ("Access"), a provider of care management
products and services to the healthcare industry through telephonic care
centers, entered into a merger agreement dated September 28, 1998, as amended.
The merger is subject to certain conditions, including the approval by Access
stockholders.

    The following financial data present on a combined pro forma basis the
condensed balance sheet of McKesson and the pro forma combined condensed balance
sheet of HBOC and Access and the condensed statements of income of McKesson and
the pro forma combined condensed statements of income of HBOC and Access. The
pro forma financial data do not reflect any cost savings or other synergies
anticipated by McKesson or HBOC management as a result of the merger. Also in
connection with the merger, the companies expect to incur charges for merger-
related costs which will be expensed in the period in which the merger is
consummated. Management has not estimated the amount of such merger-related
costs and the pro forma financial data do not reflect any such costs. The
companies may have performed differently if they had always been combined. You
should not rely on the pro forma information as being indicative of the
historical results the combined companies would have had or the results that
they will experience in the future.

    McKesson's fiscal year ends on March 31. HBOC's fiscal year ends on December
31. For purposes of combining HBOC's financial data with McKesson's historical
financial data, the financial information of HBOC has been reported on a
combined pro forma basis with Access using the twelve-month periods ended March
31, 1998, 1997 and 1996 and the six-month period ended September 30, 1998. In
addition, the financial information of HBOC has been reported assuming the
merger between HBOC and Access is consummated.

    The unaudited pro forma combined condensed consolidated
financial data should be read in conjunction with the historical financial
statements of McKesson and HBOC.

                                      4

<PAGE>
 
 
                   PRO FORMA COMBINED CONDENSED BALANCE SHEET

                             AT SEPTEMBER 30, 1998

                                 (in millions)
<TABLE> 
<CAPTION> 
                                                                                HISTORICAL                 PRO FORMA
                                                                                 MCKESSON     HBOC(1)      COMBINED
                                                                                -----------  -----------  -----------
                                                       ASSETS
<S>                                                                             <C>          <C>          <C> 
Current Assets:
  Cash and Cash Equivalents...................................................   $   103.5    $   602.6    $   706.1
  Marketable Securities Available for Sale....................................        28.1         36.3         64.4
  Receivables.................................................................     1,948.7        537.3      2,486.0
  Inventories.................................................................     3,207.2          5.7      3,212.9
  Prepaid Expenses............................................................        42.2         70.3        112.5
                                                                                -----------  -----------  -----------
    Total Current Assets......................................................     5,329.7      1,252.2      6,581.9
Property, Plant and Equipment, net............................................       479.8        138.8        618.6
Capitalized Software(2).......................................................         4.7(3)      83.2         87.9 
Goodwill and Other Intangibles................................................       828.2        160.4        988.6
Other Assets..................................................................       374.5(3)      47.7        422.2
                                                                                -----------  -----------  -----------
    TOTAL ASSETS..............................................................   $ 7,016.9    $ 1,682.3    $ 8,699.2
                                                                                ===========  ===========  ===========

                                        LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
  Drafts and Accounts Payable.................................................   $ 2,848.4    $   108.4    $ 2,956.8
  Short-term Loans and Current Portion of Long-Term Debt......................       484.9          1.2        486.1
  Other Current Liabilities...................................................       475.4        277.0        752.4
                                                                                -----------  -----------  -----------
    Total Current Liabilities.................................................     3,808.7        386.6      4,195.3
Postretirement Obligations and Other Noncurrent Liabilities...................       240.4          7.7        248.1
Long-Term Debt................................................................     1,141.5          0.9      1,142.4
McKesson-obligated mandatorily redeemable convertible preferred securities 
 of subsidiary grantor trust whose sole assets are junior subordinated 
 debentures of McKesson.......................................................       195.5         --          195.5
Stockholders' Equity..........................................................     1,630.8      1,287.1      2,917.9
                                                                                -----------  -----------  -----------
    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY................................   $ 7,016.9    $ 1,682.3    $ 8,699.2
                                                                                ===========  ===========  ===========
</TABLE> 
- ------------------------

(1) HBOC amounts are reported on a pro forma combined basis with Access, and
    have been reclassified from the historical HBOC presentation to conform to
    the McKesson financial statement presentation.

(2) Capitalized software represents costs to develop software for sale to
    customers.

(3) McKesson amounts have been reclassified from the historical McKesson
    presentation to conform to the HBOC financial statement presentation.

                                      5

<PAGE>
 

              PRO FORMA COMBINED CONDENSED STATEMENT OF INCOME

                 FOR THE SIX MONTHS ENDED SEPTEMBER 30, 1998

                   (in millions, except per share amounts)
<TABLE> 
<CAPTION> 
                                                                                                    PRO FORMA
                                                                                             ------------------------
                                                                   HISTORICAL
                                                                    MCKESSON      HBOC(1)    ADJUSTMENTS   COMBINED
                                                                   -----------  -----------  -----------  -----------
<S>                                                                <C>          <C>          <C>          <C> 
Revenues.........................................................   $12,812.4    $   863.6    $            $13,676.0
Cost and Expenses:                                                                                                
Cost of Sales and Operations.....................................    11,981.4(2)     352.3                  12,333.7
Selling, Marketing, Distribution and Administration..............       684.1(2)     172.7                     856.8
Research and Development.........................................      --             55.4                      55.4
Nonrecurring Charge..............................................      --              6.0(3)                    6.0
Interest.........................................................        57.4       --                          57.4
                                                                   -----------  -----------  -----------  -----------
      Total Cost and Expenses....................................    12,722.9        586.4       --         13,309.3
                                                                   -----------  -----------  -----------  -----------
Income before Income Taxes and Dividends on Convertible Preferred
  Securities of Subsidiary Trust.................................        89.5(2)     277.2                     366.7
Income Taxes.....................................................       (34.9)      (110.6)                   (145.5)
Dividends on Convertible Preferred Securities of Subsidiary
  Trust, net of tax benefit......................................        (3.1)      --                          (3.1)
                                                                   -----------  -----------  -----------  -----------
        Net Income...............................................   $    51.5    $   166.6    $  --        $   218.1
                                                                   ===========  ===========  ===========  ===========
Earnings Per Common Share:
Diluted..........................................................   $    0.51    $    0.35                 $    0.78
Basic............................................................   $    0.54    $    0.36                 $    0.82

Shares on which Earnings Per Common Share were based:
Diluted..........................................................       106.2        477.7       (301.0)(4)    282.9
Basic............................................................        95.6        463.4       (292.0)(4)    267.0
</TABLE> 
 ------------------------

(1) HBOC amounts are reported on a pro forma combined basis with Access, and
    have been reclassified from the historical HBOC presentation to conform to
    the McKesson financial statement presentation.

(2) Includes $80.1 million in charges ($0.7 million in Cost of Sales and
    Operations and $79.4 million in Selling, Marketing, Distribution and
    Administration) for transaction costs, employee benefit change of control
    provisions and restructuring, integration and system installation costs
    associated primarily with acquisition-related activities, $52.3 million 
    after-tax.

(3) Includes acquisition charges related to HBOC's acquisition of HPR, Inc. and
    Access' acquisition of InterQual, Inc., $3.8 million after-tax.

(4) Reflects the effect of the exchange ratio of 0.37 of a share of McKesson
    common stock for each share of HBOC common stock.


                                      6

<PAGE>
 
 
                PRO FORMA COMBINED CONDENSED STATEMENT OF INCOME

                   FOR THE TWELVE MONTHS ENDED MARCH 31, 1998

                    (in millions, except per share amounts)
<TABLE> 
<CAPTION> 
                                                                                               PRO FORMA
                                                                                        -----------------------
                                                                 HISTORICAL
                                                                  MCKESSON    HBOC(1)   ADJUSTMENTS   COMBINED
                                                                 ----------  ---------  -----------  ----------
<S>                                                              <C>         <C>        <C>          <C> 
Revenues.......................................................  $ 20,857.3  $ 1,438.6   $           $ 22,295.9
Cost and Expenses:
  Cost of Sales and Operations.................................    19,336.0      610.2                 19,946.2
  Selling, Marketing, Distribution and Administration..........     1,159.1(2)   314.9                  1,474.0
  Research and Development.....................................      --          100.6                    100.6
  Nonrecurring Charge..........................................      --          107.9(4)                 107.9
  Interest.....................................................       102.5     --                        102.5
                                                                 ----------  ---------  -----------  ----------
      Total Cost and Expenses..................................    20,597.6    1,133.6      --         21,731.2
                                                                 ----------  ---------  -----------  ----------
Income before Income Taxes and Dividends on Convertible
  Preferred Securities of Subsidiary Trust.....................       259.7 (2)  305.0                    564.7
Income Taxes...................................................       (98.6)(3) (118.2)                  (216.8)
Dividends on Convertible Preferred Securities of Subsidiary
  Trust, net of tax benefit....................................        (6.2)                               (6.2)
                                                                 ----------  ---------  -----------  ----------
      Net Income...............................................  $    154.9  $   186.8   $  --       $    341.7
                                                                 ==========  =========  ===========  ==========

Earnings Per Common Share:
  Diluted......................................................  $     1.59  $    0.40               $     1.27
  Basic........................................................  $     1.69  $    0.41               $     1.32

Shares on which Earnings Per Common Share were based:
  Diluted......................................................       101.2      469.2      (295.6)(5)     274.8
  Basic........................................................        91.5      452.5      (285.1)(5)     258.9
</TABLE> 
 ------------------------

(1) HBOC amounts are reported on a pro forma combined basis with Access, and
    have been reclassified from the historical HBOC presentation to conform to
    the McKesson financial statement presentation.

(2) Includes $16.7 million in charges for the terminated merger with AmeriSource
    Health Corporation and $13.9 million in costs associated primarily with the
    integration and rationalization of recent acquisitions, $25.4 million
    after-tax in the aggregate.

(3) Includes a non-recurring $4.6 million favorable tax adjustment.

(4) Includes acquisition charges related to HBOC's acquisitions of AMISYS
    Managed Care Systems, Inc., Enterprise Systems, Inc., HPR, Inc. and National
    Health Enhancement Systems, Inc. and the merger of Access Health, Inc. and
    Informed Access Systems Inc., $61.4 million after-tax.

(5) Reflects the effect of the exchange ratio of 0.37 of a share of McKesson
    common stock for each share of HBOC common stock.

                                      7

<PAGE>
 
 
                PRO FORMA COMBINED CONDENSED STATEMENT OF INCOME
                   FOR THE TWELVE MONTHS ENDED MARCH 31, 1997

                    (in millions, except per share amounts)
<TABLE> 
<CAPTION> 
                                                                                               PRO FORMA
                                                                                        -----------------------
                                                                 HISTORICAL
                                                                  MCKESSON    HBOC(1)   ADJUSTMENTS   COMBINED
                                                                 ----------  ---------  -----------  ----------
<S>                                                              <C>         <C>        <C>          <C> 
Revenues.......................................................  $ 15,710.8  $ 1,123.9   $           $ 16,834.7

Cost and Expenses:
Cost of Sales and Operations...................................    14,673.5      487.3                 15,160.8
Selling, Marketing, Distribution and Administration............       944.5(2)   290.9                  1,235.4
Research and Development.......................................      --           97.5                     97.5
Nonrecurring Charge............................................      --           83.5(3)                  83.5
Interest.......................................................        55.7     --                         55.7
                                                                 ----------  ---------  -----------  ----------
      Total Cost and Expenses..................................    15,673.7      959.2      --         16,632.9
                                                                 ----------  ---------  -----------  ----------
Income before Income Taxes and Dividends on Convertible
  Preferred Securities of Subsidiary Trust.....................        37.1(2)   164.7                    201.8
Income Taxes...................................................       (31.3)     (67.5)                   (98.8)
Dividends on Convertible Preferred Securities of Subsidiary
  Trust, net of tax benefit....................................        (0.7)    --                         (0.7)
                                                                 ----------  ---------  -----------  ----------
Income after Taxes:
Continuing Operations..........................................         5.1(2)    97.2      --            102.3
Discontinued Operations........................................         8.6     --                          8.6
Discontinued Operations--Gain on Sale of Armor All Stock.......       120.2     --                        120.2
                                                                 ----------  ---------  -----------  ----------
      Net Income...............................................  $    133.9  $    97.2   $  --       $    231.1
                                                                 ==========  =========  ===========  ==========
Earnings Per Common Share:
Diluted:
Continuing Operations..........................................  $     0.06  $    0.21               $     0.40
Discontinued Operations........................................        0.10     --                         0.03
Discontinued Operations--Gain on Sale of Armor All Stock.......        1.35     --                         0.46
                                                                 ----------  ---------               ----------
      Total....................................................  $     1.51  $    0.21               $     0.89
                                                                 ==========  =========  ===========  ==========
Basic:
Continuing Operations..........................................  $     0.06  $    0.22               $     0.42
Discontinued Operations........................................        0.10     --                         0.03
Discontinued Operations--Gain on Sale of Armor All Stock.......        1.41     --                         0.49
                                                                 ----------  ---------               ----------
      Total....................................................  $     1.57  $    0.22               $     0.94
                                                                 ==========  =========  ===========  ==========
Shares on which Earnings Per Common Share were based:
Diluted........................................................        89.4      458.5      (288.9)(4)    259.0
Basic..........................................................        85.5      434.7      (273.8)(4)    246.4
</TABLE> 
 

                                      8

<PAGE>
 
 
                PRO FORMA COMBINED CONDENSED STATEMENT OF INCOME
             FOR THE TWELVE MONTHS ENDED MARCH 31, 1997 (CONTINUED)


- ------------------------
(1) HBOC amounts are reported on a pro forma combined basis with Access, and
    have been reclassified from the historical HBOC presentation to conform to
    the McKesson financial statement presentation.

(2) Includes $98.8 million in charges for restructuring, asset impairment and
    other operating items and $48.2 million for the write-off of in-process
    technology related to the acquisition of McKesson Automated Healthcare Inc.,
    $109.5 million after-tax in the aggregate.

(3) Includes acquisition charges related to HBOC's acquisitions of CyCare
    Systems, Inc., Management Software, Inc. and GMIS, Inc. and the merger of
    Access Health, Inc. and Informed Access System Inc., $50.2 million 
    after-tax.

(4) Reflects the effect of the exchange ratio of 0.37 of a share of McKesson
    common stock for each share of HBOC common stock.

                                      9

<PAGE>
 
 
                PRO FORMA COMBINED CONDENSED STATEMENT OF INCOME

                   FOR THE TWELVE MONTHS ENDED MARCH 31, 1996

                    (in millions, except per share amounts)
<TABLE> 
<CAPTION> 
                                                                                                  PRO FORMA
                                                                                          -------------------------
                                                                 HISTORICAL
                                                                  MCKESSON     HBOC(1)     ADJUSTMENTS    COMBINED
                                                                 ----------  -----------  -------------  ----------
<S>                                                              <C>         <C>          <C>            <C>  
Revenues.......................................................  $ 12,964.8   $   835.9     $            $ 13,800.7

Cost and Expenses:
Cost of Sales and Operations...................................    12,049.3       384.5                    12,433.8
Selling, Marketing, Distribution and Administration............       674.2       239.5                       913.7
Research and Development.......................................      --            78.1                        78.1
Nonrecurring Charge............................................      --           136.5(2)                    136.5
Interest.......................................................        44.4        --                          44.4
                                                                 ----------  -----------       ------    ----------
      Total Cost and Expenses..................................    12,767.9       838.6          --        13,606.5
                                                                 ----------  -----------       ------    ----------
Income (Loss) Before Income Taxes..............................       196.9        (2.7)                      194.2
Income Taxes...................................................       (76.2)        0.6                       (75.6)
                                                                 ----------  -----------       ------    ----------
Income (Loss) After Taxes:
Continuing Operations..........................................       120.7        (2.1)                      118.6
Discontinued Operations........................................        14.7                                    14.7
                                                                 ----------  -----------       ------    ----------
      Net Income (Loss)........................................  $    135.4   $    (2.1)    $    --      $    133.3
                                                                 ==========  ===========       ======    ==========
Earnings (Loss) Per Common Share:
Diluted:
Continuing Operations..........................................  $     1.29   $   (0.01)                 $     0.48
Discontinued Operations........................................        0.16        --                          0.06
                                                                 ----------  -----------                 ----------
      Total....................................................  $     1.45   $   (0.01)                 $     0.54
                                                                 ==========  ===========                 ==========
Basic:
Continuing Operations..........................................  $     1.36   $   (0.01)                 $     0.51
Discontinued Operations........................................        0.17        --                          0.06
                                                                 ----------  -----------                 ----------
      Total....................................................  $     1.53   $   (0.01)                 $     0.57
                                                                 ==========  ===========                 ==========
Shares on which Earnings (Loss) Per Common Share were based:
Diluted........................................................        93.2       394.7        (238.7)(3)     249.2
Basic..........................................................        88.8       394.7        (248.7)(3)     234.8
</TABLE> 

 ------------------------
(1) HBOC amounts are reported on a pro forma combined basis with Access, and
    have been reclassified from the historical HBOC presentation to conform to
    the McKesson financial statement presentation.

(2) Includes acquisition charges related to HBOC's acquisitions of First Data
    Health Systems Corporation and CliniCom Incorporated, $81.9 million 
    after-tax.

(3) Reflects the effect of the exchange ratio of 0.37 of a share of McKesson
    common stock for each share of HBOC common stock.

                                      10



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission